Charlotte Touzalin
Tracked across 1 events · 12 articles · First seen Aug 15, 2026 · Last active Aug 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Patient who participated in the PMOS trial, experienced significant symptom improvement and weight loss, but lost access to the drug after the study ended due to insurance issues.
Aug 15, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Charlotte Touzalin live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard